Levofloxacin In The Treatment Of Children With Recurrent And/or Persistent Acute Otitis Media
Status:
Completed
Trial end date:
2005-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to demonstrate non-inferiority of levofloxacin compared with
amoxicillin/clavulanate on the clinical response at the end of therapy in infants and
children who have recurrent and/or persistent acute otitis media.
Phase:
Phase 3
Details
Lead Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.